Modern Premium vs. Established Classic
Durolane and Synvisc represent different eras and philosophies of viscosupplementation. Durolane is a modern, non-animal-derived single-injection product. Synvisc is one of the original HA products, avian-derived and delivered in a 3-injection series. Both are cross-linked, but through very different technologies.
Quick Comparison Table
| Feature | Durolane | Synvisc |
|---|---|---|
| Manufacturer | Bioventus | Sanofi |
| Source | Bacterial fermentation (NASHA) | Avian (chicken comb) |
| Bird allergy safe | Yes | No |
| Injections needed | 1 | 3 weekly |
| Volume per injection | 3 mL | 2 mL |
| Total volume | 3 mL | 6 mL |
| Cross-linking | NASHA stabilization | Hylan G-F 20 polymer |
| Molecular weight | High (NASHA) | Very high (6 million Da) |
| FDA approval | 2015 | 1997 |
| HCPCS Code | J7318 | J7325 |
| Duration | 6+ months | Up to 6 months |
| Self-pay cost | $900-$1,300 | $700-$1,000 |
What Is Durolane?
Durolane uses NASHA (Non-Animal Stabilized Hyaluronic Acid) technology developed in Sweden. The HA is produced by bacteria and then minimally cross-linked (stabilized) to create a persistent gel. Key features:
What Is Synvisc?
Synvisc (hylan G-F 20) was the first FDA-approved viscosupplement in the US in 1997. Made by Sanofi, it uses chemically cross-linked hyaluronic acid from chicken combs with the highest molecular weight of any 3-injection product.
Two Types of Cross-Linking
Both products are cross-linked, but the technology differs:
Durolane: NASHA Stabilization
- Minimal cross-linking
- Preserves more of the natural HA structure
- Creates a stabilized gel, not a heavy polymer
- Designed for single-dose persistence
- Lower reported reaction rates
Synvisc: Hylan G-F 20 Polymer
- Heavy cross-linking
- Creates a unique hylan polymer
- Very high viscosity and elasticity
- Highest molecular weight achievable
- Slightly higher pseudoseptic reaction risk
The Allergy Decision
Avian Allergies Make This Simple
Synvisc is derived from chicken combs and contains avian proteins. It is not safe for anyone with egg, chicken, or feather allergies.
Durolane is produced through bacterial fermentation with zero animal-derived ingredients. It is safe for all allergy profiles.
If you have any avian allergy and want a cross-linked product, Durolane is your answer.
Cost Breakdown
| Factor | Durolane | Synvisc |
|---|---|---|
| Drug cost (self-pay) | $900-$1,300 | $700-$1,000 |
| Office visit copays | 1 | 3 |
| Total with Medicare | $100-$200 | $150-$300 |
| Total self-pay | $925-$1,350 | $775-$1,150 |
Key insight: Durolane’s higher drug cost is partially offset by needing only one office visit. With Medicare, the total out-of-pocket costs are often very similar.
Convenience Factor
| Aspect | Durolane | Synvisc |
|---|---|---|
| Office visits | 1 | 3 |
| Weeks of treatment | Same day | 3 weeks |
| Total time commitment | 30-60 min | 3-5 hours (with travel) |
| Schedule disruption | Minimal | Moderate |
| Transportation needs | 1 trip | 3 trips |
For patients with limited mobility, transportation challenges, or busy schedules, Durolane’s single-visit convenience is a significant practical advantage.
Making Your Decision
Choose Durolane if:
- You have egg, chicken, or poultry allergies
- You prefer non-animal-derived products
- You want single-injection convenience
- Scheduling 3 weekly visits is difficult
- You want NASHA stabilization over heavy cross-linking
Choose Synvisc if:
- You have no avian allergies
- You want the highest molecular weight available
- Lower drug cost is a priority
- You value the longest safety track record (since 1997)
- You prefer more total HA volume (6 mL vs. 3 mL)
- You may want to upgrade to Synvisc-One later
Frequently Asked Questions
Is Durolane newer and therefore less proven?
Durolane was FDA-approved in 2015 for the US market but has been used in Europe since 2001. It has a strong international safety record. Synvisc has been in the US since 1997, giving it the longest domestic track record.
Can I switch from Synvisc to Durolane?
Yes. Switching is safe and may be worthwhile if you develop avian allergy concerns, want single-visit convenience, or want to try a different formulation.
Does Synvisc’s higher molecular weight make it more effective?
Studies have not shown that Synvisc’s ultra-high MW produces consistently better clinical outcomes than other products. Both Durolane and Synvisc achieve similar pain relief and duration of benefit in available studies.
Which is better for repeat treatments long-term?
Both can be repeated every 6 months. Durolane’s NASHA stabilization (minimal cross-linking) may have a theoretical advantage for long-term repeated use due to lower inflammatory reaction rates, but both products are considered safe for repeated treatment.
The Bottom Line
Durolane is the modern option combining allergy safety, minimal cross-linking, and single-visit convenience at a premium price.
Synvisc is the established classic with the highest molecular weight, more total volume, and the longest track record at a lower cost.
Both are effective, Medicare-covered treatments for knee OA. Allergies and convenience preferences are the primary differentiators.
Find HA Injection Providers
Connect with specialists offering Durolane, Synvisc, and other viscosupplementation options.
Your information is secure. See our Privacy Policy and Terms of Service.
Thank You!
We've received your request. A provider specialist will contact you within 1-2 business days to help you find the right care.
What happens next?
- 1 We'll verify your insurance coverage
- 2 Match you with quality providers in your area
- 3 Contact you to discuss your options
Questions? Browse our guides:
How to Choose a ProviderRelated Comparisons
HA Treatment Comparisons
Stay informed about viscosupplementation options for knee osteoarthritis.
Join 10,000+ readers. No spam.